Polymorphisms in the ACE I/D (4646994) and ACE2 G8790A (2285666) in Young Children Living in the Amazon Region and SARS-CoV-2 Infection.

COVID-19 infection caused by SARS-CoV-2 continues to cause significant mortality and morbidity. ACE2 is a key regulator of the renin-angiotensin-aldosterone system (RAAS). Differences in COVID-19 severity are thought to be due to the imbalance of RAAS/ACE mutations.

Are Extracorporeal Shock Waves Just a Therapeutic Tool?

Background: Focused extracorporeal shock wave therapy (ESWT) has been successfully used to treat musculoskeletal conditions, but ESWT stimulates nociceptors, causing pain deep in the tissue during treatment. The occurrence of pain during ESWT is a side effect, but it can help identify painful sites and assess minimum (MiTI) and maximum (MaTI) pain thresholds to ESWT pressure stimuli. This topic has received limited attention in literature.

Chance-constrained stochastic optimal control of epidemic models: A fourth moment method-based reformulation.

This work proposes a methodology for the reformulation of chance-constrained stochastic optimal control problems that ensures reliable uncertainty management of epidemic outbreaks. Specifically, the chance constraints are reformulated in terms of the first four moments of the stochastic state variables through the so-called fourth moment method for reliability. Moreover, a spectral technique is employed to obtain surrogate models of the stochastic state variables, which enables the efficient computation of the required statistics.

Snapshot of Fall Prevention in Patients Referred to a Neurorehabilitation Unit: A Feasibility Study on the Use of an Airbag Device.

Active wearable devices such as protective smart belts have been proposed to reduce hip impact in the event of a fall. This study primarily evaluated the feasibility and acceptance of a specific protective belt among selected patients identified as being at risk of falling who were admitted to an ICS Maugeri Neurorehabilitation Unit from September 2022 to April 2023. According to previous institutional observations, the device was worn between the 6th and 21st days of recovery.

Impact of occluder device configurations in in-silico left atrial hemodynamics for the analysis of device-related thrombus.

Left atrial appendage occlusion devices (LAAO) are a feasible alternative for non-valvular atrial fibrillation (AF) patients at high risk of thromboembolic stroke and contraindication to antithrombotic therapies. However, optimal LAAO device configurations (i.e.